Logo

PharmaShots Weekly Snapshot (March 11-15, 2019)

Share this

PharmaShots Weekly Snapshot (March 11-15, 2019)

 

 

1. ??AbCellera ?Signs a Research Agreement with Bill & Melinda Gates Foundation to Accelerate Global Health Research

Published: March 15, 2019 |Tags: Gates Foundation, Signs, Research, Agreement, AbCellera, Accelerate, Global Health Research

2. ?Abbott’s MitraClip Device Receives FDA’s Expanded Indication Approval for Secondary Mitral Regurgitation (MR)

Published: March 15, 2019 |Tags: Abbott, MitraClip, Device, Receives, FDA, Expanded, Indication, Approval, Secondary Mitral Regurgitation, MR

Roche’s MabThera (rituximab) Receives EU’s Approval for Rare Autoimmune Disease Pemphigus Vulgaris (PV)

Published: March 15, 2019 |Tags: Roche, MabThera, rituximab, Receives, EU, Approval, Rare, Autoimmune Disease, Pemphigus Vulgaris, PV

?Bayer Reports Results of Nifurtimox in P-III CHICO Study for Chagas Disease in Pediatric Patients

 Published: March 15, 2019 |Tags: Bayer, Reports, Results, Nifurtimox, P-III, CHICO, Study, Chagas Disease, Pediatric, Patients

?Merck KGaA Collaborates with Iktos for its Artificial Intelligence (AI) Technology

Published: March 15, 2019 |Tags: Merck KGaA, Collaborates, Iktos, Artificial Intelligence, AI, Technology

?Merck’s Keytruda + Chemotherapy Receive EU’s Approval for Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)

Published: March 14, 2019 |Tags: Merck, Keytruda, Chemotherapy, Receive, EU, Approval, NSCLC

Hoth Therapeutics Signs a License Agreement with UMB and Isoprene Pharmaceuticals

Published:March 14, 2019 |Tags: Hoth Therapeutics, Signs, License Agreement, UMB, Isoprene Pharmaceuticals

Roche’s Hemlibra Receives EU’s Approval for Severe Haemophilia A without Factor VIII Inhibitors

Published: March 14, 2019 |Tags: Roche, Hemlibra, Receives, EU, Approval, Severe, Haemophilia A, Factor VIII Inhibitors

Smith & Nephew to Acquire Osiris Therapeutics for $660M

Published: March 14, 2019 |Tags: Smith & Nephew, Acquire, Osiris Therapeutics, $660M

Retrotope’s RT001 Receives EMA’s Orphan Drug Designation for Infantile Neuroaxonal Dystrophy (INAD)

Published:March 14, 2019 |Tags: Retrotope, RT001, Receives, EMA, Orphan Drug Designation, Infantile Neuroaxonal Dystrophy, INAD

Sun Pharma’s SPARC Signs a Research Collaboration with HitGen to Develop Therapies

Published: March 13, 2019 |Tags:Sun Pharma, SPARC, Announces, Research, Collaboration, HitGen, Develop, Novel, Small Molecules

Exactech to Acquire XpandOrtho for its Ligament-Balancing Technology

Published: March 13, 2019 |Tags: Exactech, Acquire, XpandOrtho, Ligament-Balancinag Technology

Akebia Therapeutics Reports Positive Results of Vadadustat in P-III J01 & J03 Studies for Anemia Due to Chronic Kidney Disease (CKD) in Japan

Published: March 13, 2019 |Tags: Akebia Therapeutics, Reports, Positive, Results, Vadadustat, P-III, J01, J03, Studies, Anemia, Chronic Kidney Disease, CKD, Japan

?Secura Bio Acquires WW Commercialization Rights to Novartis’ Farydak for R/R Multiple Myeloma

Published: March 13, 2019 |Tags: Secura Bio, Acquired, WW, Commercialization, Rights, Novartis, Farydak, R/R, Multiple Myeloma

Vertex’s Symdeko (tezacaftor/ivacaftor and ivacaftor) Receives TGA’s Approval for Cystic Fibrosis with CFTR Gene Mutation in Australia?

Published: March 13, 2019 |Tags: ? Vertex, Symdeko, tezacaftor, ivacaftor, Receives, TGA, Approval, Cystic Fibrosis, CFTR Gene, Mutation, Australia

 Eli Lilly Reports Positive Results of Cyramza (ramucirumab) in P-III RELAY Study for mNSCLC?

            Published:March 12, 2019 |Tags: Eli Lilly, Reports, Positive, Results, Cyramza,   ramucirumab, P-III, RELAY, Study, mNSCLC

?             Paige.AI Receives FDA’s Breakthrough Designation for its Artificial  Intelligence in Pathology

             Published: March 12, 2019 |Tags: Paige.AI, Receives, FDA,  Breakthrough                         Designation, Artificial Intelligence, Pathology

Allergan Reports Acceptance of NDA from FDA for its Ubrogepant for Migraine

Published:March 12, 2019 |Tags: Allergen, Reports, Acceptance, NDA, FDA, Ubrogepant, Migraine

Pfizer’s Trazimera (trastuzumab-biosimilar) Receives FDA’s Approval for HER-2+ Breast Cancer and m-Gastric/GEJ Cancer?

Published:March 12, 2019 |Tags: Pfizer, Trazimera, trastuzumab-qyyp, Receives, FDA, Approval, HER-2, Overexpressing, Breast Cancer, m-Gastric Cancer

?AstraZeneca and Seres Therapeutics Enters into Research Collaboration for 3yrs.

Published: March 12, 2019 | Tags: AstraZeneca, Seres Therapeutics, Enters, Research, Collaboration, 3yrs.

?Roche’s Tecentriq + Abraxane Receive FDA’s Accelerated Approval for mTNBCa

          Published: March 11, 2019 | Tags: Roche, Tecentriq, Abraxane, Receives, FDA,                  Accelerated,  Approval, mTNBC

          Almirall's Ilumetri (tildrakizumab) Receives NICE’s Provisional Approval for                  Moderate-To-Severe       Plaque Psoriasis

           Published: March 11, 2019 |Tags: Almirall, Ilumetri, tildrakizumab, Receives, NICE,              Provisional, Approval, Moderate, Severe, Plaque Psoriasis

?MSD Signs a License Agreement with King’s College London & Wellcome’s Innovations to Develop Chronic Neuropathic Pain Therapies

Published: March 11, 2019 |Tags: MSD, Signs, License, Agreement, King’s College London, Wellcome’s Innovations, Develop, Chronic, Neuropathic, Pain, Therapies

Roche’s Ventana PD-L1 (SP142) Receives FDA’s Approval for Identifying Triple-Negative Breast Cancer (TNBC) as CDx

Published: March 11, 2019 |Tags: Roche, Ventana PD-L1 SP142, Receives, FDA, Approval, Identifying, Triple-Negative Breast Cancer, TNBC


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions